SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

SetPoint Medical's vagus nerve stimulator has received FDA approval for treating moderate-to-severe rheumatoid arthritis (RA) ...

A first-of-its-kind implant has just been granted approval from the US Food and Drug Administration (FDA) for the treatment ...

The agency’s decision was based on the outcomes of the double-blind, randomised, sham-controlled RESET-RA study.

The device stimulates the vagus nerve, signaling the body to tamp down the inflammation that contributes to the disease.

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus ...

The US Food and Drug Administration has approved a pill-sized device for treating rheumatoid arthritis, marking the first ...

The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...

SetPoint Medical Corp. has secured $30 million to launch clinical trials of a “bioelectronic” therapy that could be an alternative to medication for the inflammatory disease rheumatoid arthritis.

The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid ...